# Winchester Bancorp, Inc.: financial statements, quarterly

WSBK · Nasdaq · CIK 2047235 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wsbk.md) · [Financials](/companies/wsbk/financials.md) · [Filings](/companies/wsbk/filings.md) · [Insiders](/companies/wsbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wsbk/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $k | [56.0](/filings/0000950170-25-045817.md) | [(19.0)](/filings/0000950170-25-069255.md) | [(113) d](/filings/0001193125-25-206332.md) | [(198)](/filings/0001193125-25-277465.md) | [41.0](/filings/0001193125-26-046248.md) | [67.0](/filings/0001193125-26-221566.md) | [(566) d](/filings/0001193125-26-392194.md) | [356](/filings/0001193125-25-277465.md) | [276](/filings/0001193125-26-046248.md) | [349](/filings/0001193125-26-221566.md) | [318 d](/filings/0001193125-26-392194.md) |
| Net income | $k | [272](/filings/0000950170-25-045817.md) | [192](/filings/0000950170-25-069255.md) | [108 d](/filings/0001193125-25-206332.md) | [(632)](/filings/0001193125-25-277465.md) | [373](/filings/0001193125-26-046248.md) | [305](/filings/0001193125-26-221566.md) | [(920) d](/filings/0001193125-26-392194.md) | [962](/filings/0001193125-25-277465.md) | [1,074](/filings/0001193125-26-046248.md) | [1,145](/filings/0001193125-26-221566.md) | [1,240 d](/filings/0001193125-26-392194.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.11](/filings/0001193125-25-277465.md) | [0.12](/filings/0001193125-26-046248.md) | [0.13](/filings/0001193125-26-221566.md) | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.11](/filings/0001193125-25-277465.md) | [0.12](/filings/0001193125-26-046248.md) | [0.13](/filings/0001193125-26-221566.md) | not reported |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [44.1](/filings/0001193125-25-206332.md) | not reported | [41.5](/filings/0000950170-25-045817.md) | [66.6](/filings/0000950170-25-069255.md) | [55.2](/filings/0001193125-26-392194.md) | [57.7](/filings/0001193125-25-277465.md) | [54.8](/filings/0001193125-26-046248.md) | [54.0](/filings/0001193125-26-221566.md) | [60.0](/filings/0001193125-26-392194.md) |
| Total assets | $m | not reported | not reported | not reported | [853](/filings/0001193125-25-206332.md) | not reported | [894](/filings/0000950170-25-045817.md) | [923](/filings/0000950170-25-069255.md) | [949](/filings/0001193125-26-392194.md) | [1,005](/filings/0001193125-25-277465.md) | [1,016](/filings/0001193125-26-046248.md) | [1,057](/filings/0001193125-26-221566.md) | [1,096](/filings/0001193125-26-392194.md) |
| Total liabilities | $m | not reported | not reported | not reported | [773](/filings/0001193125-25-206332.md) | not reported | [814](/filings/0000950170-25-045817.md) | [842](/filings/0000950170-25-069255.md) | [834](/filings/0001193125-26-392194.md) | [888](/filings/0001193125-25-277465.md) | [898](/filings/0001193125-26-046248.md) | [938](/filings/0001193125-26-221566.md) | [975](/filings/0001193125-26-392194.md) |
| Shareholders' equity | $m | [78.0](/filings/0000950170-25-045817.md) | [79.1](/filings/0000950170-25-069255.md) | [79.3](/filings/0000950170-25-069255.md) | [80.3](/filings/0001193125-26-392194.md) | [80.2](/filings/0001193125-26-046248.md) | [80.3](/filings/0001193125-26-221566.md) | [80.9](/filings/0001193125-26-221566.md) | [115](/filings/0001193125-26-392194.md) | [117](/filings/0001193125-26-046248.md) | [118](/filings/0001193125-26-221566.md) | [119](/filings/0001193125-26-221566.md) | [121](/filings/0001193125-26-392194.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(357) d](/filings/0000950170-25-069255.md) | [(216) d](/filings/0001193125-25-206332.md) | [(334)](/filings/0001193125-25-277465.md) | [57.0 d](/filings/0001193125-26-046248.md) | [848 d](/filings/0001193125-26-221566.md) | [1,894 d](/filings/0001193125-26-392194.md) | [1,357](/filings/0001193125-25-277465.md) | [1,551 d](/filings/0001193125-26-046248.md) | [1,356 d](/filings/0001193125-26-221566.md) | [1,133 d](/filings/0001193125-26-392194.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,965](/filings/0001193125-25-277465.md) | [8,969](/filings/0001193125-26-046248.md) | [8,973](/filings/0001193125-26-221566.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,295,376 at 2026-09-10, from the cover of the [10-K filed 2026-09-16](/filings/0001193125-26-392194.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.